Stock Information
Natera Inc (NTRA)
Ticker Symbol: NTRA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $28,704.25 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -1.5333
Revenue (TTM): $16.67 M
Dividend Yield: N/A%
ROE: -15.28%
Latest News
-
Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery
Tue, Mar 31, 2026 12:48 PM
-
Natera shares are trading higher after the company announced a Clinical Cancer Research article showing that Signatera was able to identify older women with early-stage ER+/HER2- breast cancer who can be managed with primary endocrine therapy without surgery.
Tue, Mar 31, 2026 6:59 AM
-
Natera Study Shows Signatera MRD Identifies Older ER Positive HER2 Negative Breast Cancer Patients Who Can Forgo Surgery And Remain Progression Free
Tue, Mar 31, 2026 6:05 AM
Key Financials
Financial data not available
